Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2017 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.
Regul Toxicol Pharmacol. 2018 Aug;97:17-23. doi: 10.1016/j.yrtph.2018.05.014. Epub 2018 May 29.
Regul Toxicol Pharmacol. 2018.
PMID: 29857115
Free PMC article.
Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations.
Pai AB, Meyer DE, Bales BC, Cotero VE, Pai MP, Zheng N, Jiang W.
Pai AB, et al.
Clin Transl Sci. 2017 May;10(3):194-200. doi: 10.1111/cts.12443. Epub 2017 Feb 3.
Clin Transl Sci. 2017.
PMID: 28160427
Free PMC article.
Item in Clipboard
Considerations and challenges in defining optimal iron utilization in hemodialysis.
Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, Kovesdy CP, Fishbane S; Dialysis Advisory Group of the American Society of Nephrology.
Charytan DM, et al.
J Am Soc Nephrol. 2015 Jun;26(6):1238-47. doi: 10.1681/ASN.2014090922. Epub 2014 Dec 26.
J Am Soc Nephrol. 2015.
PMID: 25542967
Free PMC article.
Review.
Item in Clipboard
Cite
Cite